GNT Induction Treatment in Locally Advanced NPC

PHASE3RecruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

gemcitabine,nimotuzumab, toripalimab

same as before

DRUG

gemcitabine, cisplatin

same as before

Trial Locations (1)

710032

RECRUITING

Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER